Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06260072 · ClinicalTrials.gov registry record · Phase 2
Magnesium and Riboflavin Treatment for Post-Concussion Headache
A Phase 2 study of Concussion, Intermediate, sponsored by University of Virginia.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06260072 is a Phase 2 study of Concussion, Intermediate that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 108 participants, below the 247-participant average among 5 other Concussion, Intermediate trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06260072, a Phase 2 study of Concussion, Intermediate, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Conditions Studied
Interventions
- DRUG magnesium and riboflavin supplement
Study Locations (1)
Virginia
- University of Virginia Student Health and Wellness Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06260072
The ClinicalTrials.gov registry entry for NCT06260072 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 247-participant average among 5 other Concussion, Intermediate trials with a reported enrollment target (56% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Concussion, Intermediate appearing as the primary indexed condition, and to 1 intervention - of which magnesium and riboflavin supplement is the first listed.
NCT06260072 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06260072 about?
NCT06260072 is a clinical study titled "Magnesium and Riboflavin Treatment for Post-Concussion Headache". This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules...
What is the current status of trial NCT06260072?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2020-02-10. Estimated completion is 2025-12-31.
What conditions does trial NCT06260072 study?
This clinical trial studies the following conditions: Concussion, Intermediate.
What interventions are being tested in trial NCT06260072?
The interventions under investigation include: magnesium and riboflavin supplement (DRUG).
Who is sponsoring clinical trial NCT06260072?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06260072 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussion, Intermediate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Facilitating Access to Specialty Treatment
RECRUITING · NA
-
Intervention to Change Affect Recognition and Empathy
ACTIVE NOT RECRUITING · NA
-
Unblinded Data Collection Study of Concussion Using BrainPulse
COMPLETED
-
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
COMPLETED
-
Objective Brain Function Assessment of mTBI/Concussion
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.